Chong Chyn Chua - Walter and Eliza Hall Institute of Medical Research

基本信息

Career Trajectory

Bio

-Haematologist (AML lead), Monash Hospital, Melbourne -Head of Malignant Haematology and Haematology clinical trials, Northern Hospital, Epping,l - Research Fellow, Walter and Eliza Hall Institute of medical research, Melbourne Australia

Research Interests

Papers共 61 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

High Burden and Poor Outcomes of Myelodysplastic Neoplasms (MDS) in the Real-World: a 10-Year Audit of Three Australian Hospitals

Zoe Loh,Michael Ashby, Marzia Rahman, Evangeline Y Wong,Doen Ming Ong,Susan Morgan,Chong Chyn Chua

Leukemia & lymphomano. 6 (2025): 1162-1165

Cited0Views0WOSBibtex

Single-cell Rapid Capture Hybridization Sequencing (Scrach-Seq) to Reliably Detect Isoform Usage and Coding Mutations in Targeted Genes at a Single-Cell Level

Hongke Peng,Jafar S Jabbari,Luyi Tian, Changqing Wang, Yupei You,Chong Chyn Chua,Natasha S Anstee, Noorul Amin,Andrew H Wei,Nadia M Davidson,Andrew W Roberts,David C S Huang,Matthew E Ritchie,Rachel Thijssen

Genome researchno. 4 (2025): 942-955

Cited1Views0WOSBibtex

Final Analysis of the Phase 1b Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT)

Chong Chyn Chua,Sun Loo,Chun Yew Fong,Stephen B Ting,Ing Soo Tiong,Shaun Fleming,Natasha S Anstee,Adam Ivey,Michael Ashby, Tse-Chieh Teh,John Reynolds, Andrew W Roberts,Andrew H Wei

Blood Advances (2025)

Cited0Views0WOSBibtex

Low-intensity Venetoclax-Based Salvage As a Bridge to Allogeneic Stem Cell Transplant in Patients with Acute Myeloid Leukemia Failing Conventional Intensive Chemotherapy

Michael Ashby,Shaun Fleming,Tse-Chieh Teh,Ing Soo Tiong,Shafqat Inam,David J. Curtis,Sushrut Patil,Catherine Vassili,Chong Chyn Chua

Leukemia Research（2024）

Cited1Views0WOSBibtex

Time to Define and Refine Maintenance Strategies in Acute Myeloid Leukaemia

Chong Chyn Chua,Andres Gomez-De Leon

The Lancet Haematology（2024）

Cited1Views0WOSBibtex

High Burden of Healthcare Utilization in Older Acute Myeloid Leukemia Patients Treated with First-Line Venetoclax-Based Therapies

Shreyas Khanna, Harini Haran, Thomas Wiseman, Kevin Hung, Aidan Sapio,Philip Selby, Michaela Spooner,David T Yeung,Daniel Thomas, Chung How Kok,Andrew H Wei,Chong Chyn Chua,Devendra Hiwase

Bloodno. Supplement 1 (2024): 4237-4237

Cited0Views0Bibtex

Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML with Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC)

Ing Soo Tiong,Devendra K. Hiwase,Emad Abro,Ashish Bajel,Emma Palfreyman,Ashanka Beligaswatte,John Reynolds,Natasha Anstee,Tamia Nguyen,Sun Loo,Chong Chyn Chua, Michael Ashby, Kaitlyn M. Wiltshire,Shaun Fleming,Chun Y. Fong,Tse-Chieh Teh,Piers Blombery,Richard Dillon,Adam Ivey,Andrew H. Wei

JOURNAL OF CLINICAL ONCOLOGYno. 18 (2024)

Cited4Views0WOSBibtex

Real-world Utility of Cytogenetic Testing in Cases with ‘suspected Myelodysplastic Neoplasm but Insufficient Morphological Features for Diagnosis’: a Victorian Cancer Cytogenetics Service Experience

Holly Pertile,Kenneth J.C. Lim,Chong Chyn Chua, Merrole Cole-Sinclair,Karen Dun,Slavisa Ninkovic

Pathology（2024）

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn